Kamada (KMDA) Change in Accured Expenses (2012 - 2026)

Kamada (KMDA) posted quarterly Change in Accured Expenses of -$1.9 million for Q1 2026, up 7.19% year-on-year from -$1.8 million in Q1 2025, and down 257.69% on a QoQ basis from $1.2 million in Q4 2025.

Kamada (KMDA) Change in Accured Expenses (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Change in Accured Expenses for 15 consecutive years, with -$1.9 million the latest figure, recorded in Q1 2026.

  • Quarterly Change in Accured Expenses rose 7.19% year-over-year to -$1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (down 22.75% YoY) and the FY2025 annual result came in at $950000.0, down 32.77% from the prior year.
  • Change in Accured Expenses declined to -$1.9 million in Q1 2026 per KMDA's latest filing, from $1.2 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for KMDA reached as high as $1.6 million in Q4 2024 and fell as low as -$2.1 million in Q1 2024.
  • A 5-year average of -$2731.2 and a median of $2083.0 in 2022 frame the typical range for Change in Accured Expenses.
  • Annual changes were most pronounced in 2023 — Change in Accured Expenses jumped 407346.38% — and 2024, when it slumped 861664.71%.
  • Year by year, Change in Accured Expenses stood at -$276.0 in 2022, then soared by 407346.38% to $1.1 million in 2023, then jumped by 39.68% to $1.6 million in 2024, then fell by 23.38% to $1.2 million in 2025, then tumbled by 257.69% to -$1.9 million in 2026.
  • According to Business Quant data, Change in Accured Expenses over the past three periods registered -$1.9 million, $1.2 million, and $630000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Haleon 89.86 Bn 88.00 Bn - -
2 Teva Pharmaceutical Industries 35.98 Bn 32.24 Bn 1.97 Bn -144.00 Mn
3 Zoetis 32.48 Bn 30.54 Bn 1.62 Bn -234.00 Mn
4 Takeda Pharmaceutical 27.56 Bn 23.49 Bn 4.39 Bn -
5 United Therapeutics 23.01 Bn 20.86 Bn 648.10 Mn -12.70 Mn
6 RedHill Biopharma 22.02 Bn 22.02 Bn - -
7 Viatris 20.40 Bn 18.59 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.77 Bn 16.46 Bn 800.70 Mn -14.30 Mn
9 Elanco Animal Health 12.74 Bn 12.31 Bn 785.00 Mn -
10 Kamada 399.49 Mn 326.34 Mn 19.12 Mn -1.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.90 Mn
Mar 31, 2026 -1.90 Mn
Dec 31, 2025 1.20 Mn
Dec 31, 2025 1.20 Mn
Sep 30, 2025 630,000.00
Sep 30, 2025 630,000.00
Jun 30, 2025 1.16 Mn
Jun 30, 2025 1.16 Mn
Mar 31, 2025 -2.04 Mn
Mar 31, 2025 -2.04 Mn
Dec 31, 2024 1.57 Mn
Dec 31, 2024 1.57 Mn
Sep 30, 2024 881,000.00
Sep 30, 2024 881,000.00
Jun 30, 2024 1.01 Mn
Jun 30, 2024 1.01 Mn
Mar 31, 2024 -2.05 Mn
Mar 31, 2024 -2.05 Mn
Dec 31, 2023 1.12 Mn
Dec 31, 2023 1.12 Mn